Source link : https://www.newshealth.biz/health-news/year-in-review-rsv-medpage-today/
This year’s headlines on respiratory syncytial virus (RSV) focused largely on the relatively new vaccines — including a new option, expanded FDA approvals, and updated CDC recommendations — plus a potential new monoclonal antibody for protecting infants. FDA Approvals and Expansions In May, the FDA approved the mRNA-1345 RSV vaccine (mResvia) from Moderna for people […]
Author : News Health
Publish date : 2024-11-08 15:00:00
Copyright for syndicated content belongs to the linked Source.
inHealth